AGR2 and breast cancer: Serum samples from 154 dogs with mammary tumors (31 benign, 123 malignant) and 39 healthy controls were analyzed using a custom multiplex immunoassay detecting autoantibodies against AGR2, HAPLN1, IGFBP5, and TYMS, normalized to anti-BSA levels.